Elevance Health logo

Elevance HealthNYSE: ELV

Profile

Sector:

Healthcare

Country:

United States

IPO:

30 October 2001

Next earnings report:

24 January 2025

Last dividends:

10 September 2024

Next dividends:

05 December 2024
$91.66 B
-29%vs. 3y high
99%vs. sector
-33%vs. 3y high
20%vs. sector
-42%vs. 3y high
58%vs. sector
-39%vs. 3y high
14%vs. sector

Price

regular market | 10 min ago
$395.46-$3.04(-0.76%)
$45.15 B$44.54 B
$45.15 B$1.02 B

Analysts recommendations

Institutional Ownership

ELV Latest News

Elevance Health Declines 20% in 3 Months: Time to Sell the Stock?
zacks.com12 November 2024 Sentiment: NEGATIVE

ELV is facing challenges like rising benefit costs, a higher level of debt, and losing members in its Medicaid sector, which worries investors.

Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com07 November 2024 Sentiment: NEGATIVE

SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The law firm Johnson Fistel, LLP is looking into whether Elevance Health, Inc. (NYSE: ELV) or its executives broke securities laws by not properly informing investors about important negative information. The investigation is centered on the losses suffered by investors and if they can be recovered under federal securities laws.

What's Behind The 15% Fall For Elevance Health Stock?
forbes.com21 October 2024 Sentiment: NEUTRAL

Elevance Health (NYSE: ELV) has just announced its Q3 results, showing that its revenue was higher than expected, but its earnings fell short of predictions. The company generated $44.7 billion in revenue and adjusted earnings of $8.37 per share, while analysts had estimated $43.5 billion in revenue and $9.66 in earnings.

These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings
benzinga.com18 October 2024 Sentiment: NEGATIVE

On Thursday, Elevance Health Inc. (ELV) announced that its earnings for the third quarter were lower than anticipated.

Elevance Health Stock: Looking Beyond Near-Term Issues, I'm A Buyer
seekingalpha.com18 October 2024 Sentiment: POSITIVE

Elevance Health's results for the third quarter of 2024 were not as good as expected, with a notable rise in the benefit expense ratio and reduced earnings forecasts for the year. I examine how much ELV relies on government plans and how profitable they are. Despite this, I believe Elevance stock is reasonably priced, even with cautious growth predictions for the near and long term.

S&P 500 Gains and Losses Today: Health Insurers Slide as Elevance Cites Medicaid Declines
investopedia.com17 October 2024 Sentiment: NEUTRAL

The main U.S. stock indexes showed varied results as earnings from Taiwan Semiconductor Manufacturing (TSM) boosted hope for artificial intelligence (AI), and September retail sales figures exceeded expectations.

Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
seekingalpha.com17 October 2024 Sentiment: NEGATIVE

Elevance Health's earnings report for the third quarter resulted in a 14% decrease in its stock price because of a higher benefit expense ratio and lower earnings per share. The health insurance sector is struggling, especially with Medicare Advantage and Medicaid, which is impacting profits and leading to falling share prices across the industry. While Elevance's management anticipates revenue growth in 2025, they recognize that profitability challenges remain, indicating a careful outlook for the near future.

Elevance Health's Q3 Earnings Miss Due to Medicaid Redeterminations
zacks.com17 October 2024 Sentiment: NEUTRAL

ELV's earnings for the third quarter have been negatively affected by a drop in Medicaid and Medicare membership, although this was somewhat balanced by an increase in product sales.

Why Is Elevance Health Stock Trading Lower On Thursday?
benzinga.com17 October 2024 Sentiment: POSITIVE

On Thursday, Elevance Health Inc. (ELV) announced its third-quarter revenues reached $44.7 billion, which is a 5.3% increase compared to the same period last year. This figure surpassed the expected revenue of $43.33 billion.

Elevance Health (ELV) Q3 Earnings Lag Estimates
zacks.com17 October 2024 Sentiment: NEUTRAL

Elevance Health (ELV) reported quarterly earnings of $8.37 per share, which is lower than the Zacks Consensus Estimate of $9.70 per share. This is a decrease compared to earnings of $8.99 per share from the same period last year.

What type of business is Elevance Health?

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

What sector is Elevance Health in?

Elevance Health is in the Healthcare sector

What industry is Elevance Health in?

Elevance Health is in the Healthcare Plans industry

What country is Elevance Health from?

Elevance Health is headquartered in United States

When did Elevance Health go public?

Elevance Health initial public offering (IPO) was on 30 October 2001

What is Elevance Health website?

https://www.elevancehealth.com

Is Elevance Health in the S&P 500?

Yes, Elevance Health is included in the S&P 500 index

Is Elevance Health in the NASDAQ 100?

No, Elevance Health is not included in the NASDAQ 100 index

Is Elevance Health in the Dow Jones?

No, Elevance Health is not included in the Dow Jones index

When was Elevance Health the previous earnings report?

No data

When does Elevance Health earnings report?

The next expected earnings date for Elevance Health is 24 January 2025